Showcases & Background Setting Bar

Showcases

Background Image

This setting is only taking a look when select color and background.
If you want to set showcase color, background and disable Setting Bar, go to Templates Manager > AT-Templates > Global Tab

Dossiers d'AMM à évaluer par la commission spécialisée de Carcinologie du 22/02/2022

NOM  DCI DOSAGE FORME PRESENTATION G/P LABORATOIRE
1 KEYTRUDA PEMBROLIZUMAB 25 mg/ml Solution à diluer pour perf B/1FL/4ML P MERCK  SHARP & DOHME B.V
2 PHESGO PERTUZUMAB + TRASTUZUMAB 1200 mg/600 mg Solution injectable B/1Fl/15 ml P ROCHE REGISTRATION GMBH
3 PHESGO PERTUZUMAB + TRASTUZUMAB 600 mg/600 mg Solution injectable B/1Fl/10 ml P ROCHE REGISTRATION GMBH
4 CYRAMZA RAMUCIRUMAB 10 mg/ml Solution à diluer pour perf B/1FL/50ML P ELI LILLY AND COMPAGNY
5 CASODEX BICALUTAMIDE 50 MG Comprime enrobé B/30 P JUVISE PHARMACEUTICALS
6 BICALUTAMIDE NEAPOLIS BICALUTAMIDE 150 mg Comprimé pelliculé B/30 G NEAPOLIS PHARMA
7 CABAZITAXEL NEAPOLIS CABAZITAXEL 10 mg/ml Solution injectable pour perf B/1FL/4.5 ml G NEAPOLIS PHARMA
8 CABAZITAXEL NEAPOLIS CABAZITAXEL 10 mg/ml Solution injectable pour perf B/1FL/6 ml G NEAPOLIS PHARMA
9 MESNA NEAPOLIS MESNA 400 mg/4 ml Solution injectable B/5/4ML G NEAPOLIS PHARMA
10 CYTOTREXATE HD 500/5 METHOTREXATE 100 MG/ML Solution injectable B/1FL/5ml G CYTOPHARMA
11 EPIRUBICIN AQVIDA EPIRUBICINE 2 MG/ML 50 mg/25 ml Solution injectable pour perf B/1FL/25 ml G AQVIDA GMBH
12 EPIRUBICIN AQVIDA EPIRUBICINE 2 MG/ML 10 mg/25 ml Solution injectable pour perf B/1FL/5ml G AQVIDA GMBH
13 AVASTIN BEVACIZUMAB 100 mg Solution injectable pour perf B/1FL/4ml P Roche Pharma (Schweiz) AG
14 AVASTIN BEVACIZUMAB 400 mg Solution injectable pour perf B/1FL/16ml P Roche Pharma (Schweiz) AG
15 EMEND APREPITANT 80mg/125mg Gélule B/3 P MERCK  SHARP & DOHME B.V
16 PIQRAY ALPELISIB 150 mg Comprimé pelliculé B/ 56 P NOVARTIS PHARMA SCHWEIZ AG
17 PIQRAY ALPELISIB 200 mg Comprimé pelliculé B/28 P NOVARTIS PHARMA SCHWEIZ AG
18 PIQRAY ALPELISIB 200 mg+ 50mg Comprimé pelliculé B/28 + 28 P NOVARTIS PHARMA SCHWEIZ AG

Actualités

Powered by Amazing-Templates.com 2014 - All Rights Reserved.